References
- Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand. J. Infect. Dis. 43(9), 683–689 (2011).
- Payne DC, Staat MA, Edwards KM et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 122(6), 1235–1243 (2008).
- Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Cost–effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 119(4), 684–697 (2007).
- Velázquez FR, Matson DO, Calva JJ et al. Rotavirus infections in infants as protection against subsequent infections. N. Engl. J. Med. 335(14), 1022–1028 (1996).
- Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 354(1), 11–22 (2006).
- Vesikari T, Matson DO, Dennehy P et al.; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 354(1), 23–33 (2006).
- Tate JE, Panozzo CA, Payne DC et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 124(2), 465–471 (2009).
- Cortes JE, Curns AT, Tate JE et al. Rotavirus vaccine and health care utilization for diarrhea in US children. N. Engl. J. Med. 365(12), 1108–1117 (2011).
- Payne DC, Staat MA, Edwards KM et al.; New Vaccine Surveillance Network (NVSN). Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006–2009. Clin. Infect. Dis. 53(3), 245–253 (2011).
- Anderson EJ, Rupp A, Shulman ST, Wang D, Zheng X, Noskin GA. Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children. Pediatrics 127(2), e264–e270 (2011).
- Pitzer VE, Viboud C, Simonsen L et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science 325(5938), 290–294 (2009).
- Tate JE, Mutuc JD, Panozzo CA et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr. Infect. Dis. J. 30(Suppl. 1), S30–S34 (2011).
- National, state, and local area vaccination coverage among children aged 19–35 months – United States, 2011. MMWR. Morb. Mort. Weekly Rep. 61, 689–696 (2012).
- Anderson EJ, Weber SG. Rotavirus infection in adults. Lancet Infect. Dis. 4(2), 91–99 (2004).
- Anderson EJ, Katz BZ, Polin JA, Reddy S, Weinrobe MH, Noskin GA. Rotavirus in adults requiring hospitalization. J. Infect. 64(1), 89–95 (2012).
- Cardemil CV, Cortese MM, Medina-Marino A et al.; Rotavirus Investigation Team. Two rotavirus outbreaks caused by genotype G2P[4] at large retirement communities: cohort studies. Ann. Intern. Med. 157(9), 621–631 (2012).
- Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J. Infect. Dis. 204(7), 980–986 (2011).
- Anderson EJ, Shippee DB, Weinrobe MH et al. Indirect protection of adults from rotavirus by pediatric rotavirus vaccination. Clin. Infect. Dis. 56(6), 755–760 (2013).
Websites
- Payne DC; Update on rotavirus vaccines in the United States. Advisory Committee on Immunization Practices (ACIP) presentation slides: October 2012 meeting. www.cdc.gov/vaccines/acip/meetings/downloads/slides-oct-2012/00-Rotavirus-Payne.pdf (Accessed 2 April 2013)
- CDC. Rotavirus National Trends. www.cdc.gov/surveillance/nrevss/rotavirus/natl-trend.html (Accessed 2 April 2013)